Clinical course features of newly diagnosed pulmonary tuberculosis treatment failure

被引:0
|
作者
Yasinskyi, R. M. [1 ]
Kovalenko, O. O. [2 ]
Smirnova, V. V. [2 ]
Krasnevich, A. M. [3 ]
机构
[1] Zaporizhzhia State Med Univ, Dept Phthisiol & Pulmonol, Zaporizhia, Ukraine
[2] Zaporizhzhia Reg Council, Municipal Inst Zaporizhzhia Reg Clin TB Dispensar, Pulm TB Dept 1, Zaporizhia, Ukraine
[3] Zaporizhzhia Reg Council, Municipal Inst Zaporizhzhia TB Dispensary 4, Zaporizhia, Ukraine
关键词
Tuberculosis; Treatment Failure;
D O I
10.14739/2310-1210.2016.3.76982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Percentage of patients with newly diagnosed tuberculosis treatment failure is 22.6 % in the world and is approximately 12% according to the official statistics in Zaporizhzhia. Aim. To establish anamnestic, clinical-radiographic and laboratory features of the tuberculosis course in patients with newly diagnosed tuberculosis treatment failure. Materials and methods. A retrospective analysis of 88 patient's histories who were treated at the Zaporizhzhia Regional Clinical Tuberculosis Dispensary in 2013-2015 years was carried out. Patients were divided into 2 groups: 49 patients with treatment failure (TF) have been included into 1st group, 39 people who successfully completed the course of therapy (NDTB) were in the 2nd group. Results. It was found that 63.3% of TF patients carried fluorography untimely and 26.6% have not been inspected more than 5 years, p<0.05. Infiltrative (55.1%) and disseminative (34.7%) tuberculosis clinical forms in TF patients prevailed in the structure of the lung lesions. Approximately 90% of TF patients had lung lesion volume more than one lobe or both of the lungs (p<0.001) with the presence of several or multiple destructions in 79% of patients with a size greater than 3 cm in 56% of patients compared with the fact, that 46% of patients with NDTB limited tuberculosis diagnosed with single or several destructions with sizes up to 3 cm in 86% cases, p<0.05. When TF percentage of patients with massive bacterial excretion prevailed, p<0.05. In the presence of drug resistance in 70% polyresistance determined, whereas 26% of NDTB bacterial excretion was determined only by culture methods and in resistance cases it was monoresistance in 67% patients. Terms of bacteriological conversion at TF were 6.3 +/- 0.2 months and greater than 6 months in 30.6% of patients. Destruction not healed in 85.4 % of patients, but in most cases, their sizes did not exceed 2 cm at the end of treatment. Long terms of bacteriological conversion and destructions healing in TF patients demonstrate the necessity for long-term etiotropic therapy in patients with smear-massive bacterial excretion and disseminative destructive tuberculosis. The low proportion of destructions healing in these patients determines searchings' for ways to the timely surgical and complex pathogenetic treatment.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [21] SHORT-COURSE DAILY AND INTERMITTENT REGIMENS IN TREATMENT OF NEWLY DETECTED PULMONARY TUBERCULOSIS
    ZIERSKI, M
    BRITISH JOURNAL OF DISEASES OF THE CHEST, 1978, 72 (03): : 258 - 258
  • [22] Association of Vitamin D Deficiency in Newly Diagnosed Pulmonary Tuberculosis
    Ullah, Khalil
    Rehman, Sajid Ur
    Nadeem, Ramsha
    Abubakar, Muhammad
    Raza, Qasim
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2572 - 2573
  • [23] TOXICITY IN NEWLY DIAGNOSED CASES OF PULMONARY TUBERCULOSIS TREATED WITH ETHIONAMIDE
    LEES, AW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1963, 88 (03): : 347 - +
  • [24] Cigarette smoking in patients newly diagnosed with pulmonary tuberculosis in Iran
    Aryanpur, M.
    Masjedi, M. R.
    Hosseini, M.
    Mortaz, E.
    Tabarsi, P.
    Soori, H.
    Emami, H.
    Heydari, G.
    Baikpour, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 679 - 684
  • [25] Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis
    Jaimni, Vijay
    Shasty, Barkur Ananthakrishna
    Madhyastha, Sharath P.
    Shetty, Ganesh V.
    Acharya, Raviraja V.
    Bekur, Ragini
    Doddamani, Akhila
    PULMONARY MEDICINE, 2021, 2021
  • [26] Cigarette smoking in patients newly-diagnosed with pulmonary tuberculosis
    Aryanpur, Mahshid
    Masjedi, Mohammad Reza
    Mortaz, Esmaeil
    Hessami, Zahra
    Aryan, Mohammad Reza
    Heydari, Gholamreza
    Hossei, Mostafa
    Sharifi, Hooman
    Baikpour, Masoud
    Tabarsi, Payam
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [27] Rifabutin for the treatment of newly diagnosed pulmonary tuberculosis: A multinational randomized comparative study versus rifampicin
    Gupta, ML
    Bhattacharya, P
    TUBERCLE AND LUNG DISEASE, 1995, 76 (06): : 582 - 582
  • [28] Changes of the pro-hormone levels of vitamin D 25(OH)D in patients with newly diagnosed pulmonary tuberculosis treatment failure
    Yasinskyi, R. M.
    Raznatovska, O. M.
    PATHOLOGIA, 2020, (01): : 68 - 74
  • [29] Delayed treatment of diagnosed pulmonary tuberculosis in Taiwan
    Chern, Jimmy P. S.
    Chen, Duan-Rung
    Wen, Tzai-Hung
    BMC PUBLIC HEALTH, 2008, 8 (1)
  • [30] Delayed Treatment of Diagnosed Pulmonary Tuberculosis in Taiwan
    Jimmy PS Chern
    Duan-Rung Chen
    Tzai-Hung Wen
    BMC Public Health, 8